DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Manns M, Marcellin P, Poordad F. et al.
Simeprevir with pegylated interferon alfa 2a or 2b plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-2): a randomised, double-blind, placebo-controlled phase 3 trial.
Lancet 2014;
384 (9941): 414-426
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.